Free Trial

Intuitive Surgical (NASDAQ:ISRG) Shares Unloaded Rep. Josh Gottheimer

Intuitive Surgical logo with Medical background

Representative Josh Gottheimer (D-New Jersey) recently sold shares of Intuitive Surgical, Inc. NASDAQ: ISRG. In a filing disclosed on January 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in Intuitive Surgical stock on December 23rd. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account.

Representative Josh Gottheimer also recently made the following trade(s):

  • Purchased $1,001 - $15,000 in shares of Block NYSE: SQ on 12/30/2024.
  • Purchased $1,001 - $15,000 in shares of The Goldman Sachs Group NYSE: GS on 12/30/2024.
  • Sold $1,001 - $15,000 in shares of Ambev NYSE: ABEV on 12/27/2024.
  • Sold $1,001 - $15,000 in shares of Grupo Financiero Banorte OTCMKTS: GBOOY on 12/27/2024.
  • Sold $1,001 - $15,000 in shares of Cadre NYSE: CDRE on 12/27/2024.
  • Sold $1,001 - $15,000 in shares of Coloplast A/S OTCMKTS: CLPBY on 12/27/2024.
  • Sold $1,001 - $15,000 in shares of Trane Technologies NYSE: TT on 12/23/2024.
  • Purchased $1,001 - $15,000 in shares of Walmart NYSE: WMT on 12/20/2024.
  • Sold $1,001 - $15,000 in shares of NVIDIA NASDAQ: NVDA on 12/19/2024.
  • Purchased $1,001 - $15,000 in shares of Walmart NYSE: WMT on 12/19/2024.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded up $3.97 on Thursday, hitting $584.08. 2,119,290 shares of the company were exchanged, compared to its average volume of 1,655,838. The company's 50 day moving average price is $538.34 and its two-hundred day moving average price is $497.08. Intuitive Surgical, Inc. has a one year low of $355.17 and a one year high of $585.50. The firm has a market capitalization of $208.04 billion, a price-to-earnings ratio of 93.90, a PEG ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion during the quarter, compared to analysts' expectations of $2.01 billion. Research analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Activity

In other news, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,314,795.00. Following the transaction, the executive vice president now owns 7,066 shares of the company's stock, valued at $3,638,990. This represents a 26.54 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the sale, the executive vice president now directly owns 5,506 shares of the company's stock, valued at approximately $2,788,899.12. This trade represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 48,190 shares of company stock valued at $25,012,927. 0.80% of the stock is currently owned by insiders.

Institutional Trading of Intuitive Surgical

Several hedge funds have recently modified their holdings of the stock. Massachusetts Financial Services Co. MA bought a new position in Intuitive Surgical in the 3rd quarter valued at $558,807,000. International Assets Investment Management LLC boosted its holdings in Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider's stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the last quarter. FMR LLC increased its position in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB increased its position in Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock worth $272,980,000 after purchasing an additional 552,058 shares during the period. Finally, State Street Corp lifted its position in Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the period. 83.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts recently commented on ISRG shares. Mizuho raised their target price on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Evercore ISI reiterated a "cautious" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Royal Bank of Canada increased their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an "outperform" rating in a research report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. Finally, Leerink Partners upped their price objective on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $554.17.

Read Our Latest Stock Analysis on ISRG

About Representative Gottheimer

Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey's 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2025. Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey's 5th Congressional District. He declared candidacy for the 2024 election. Gottheimer was first elected to the House in 2016. Prior to his election, Gottheimer worked for Microsoft, the Federal Communications Commission, and for the administration of President Bill Clinton (D). Click here for more information about Gottheimer's career. Gottheimer serves on the House Financial Services Committee, where is a member of three subcommittees. For more on Gottheimer's committee assignments, click here. Gottheimer became a co-chair of the Problem Solvers Caucus in February 2017. Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines